Topic: patent expirations
Acorda faces the prospect of generic competition on its primary revenue source, Ampyra, after an appeals court's decision.
AbbVie has filed for a whopping 247 patent on Humira, an example of how drugmakers try to forestall copycat competition.
Pfizer CEO Ian Read contends that the company's pipeline is strong enough to fuel growth. In other words, don't look for a "transformative" deal.
Pfizer’s board of directors is providing rich incentives to keep CEO Ian Read on board as the company navigates a host of challenges.